PCMag on MSN7h
Boom Supersonic: Our Flights Can Break Sound Barrier Without a Sonic Boom
During the second supersonic flight of the XB-1 technology demonstrator today, the jet exceeded Mach 1 three times without a ...
Adelaide City Council is progressing plans to transform Light Square into green space
Adelaide City Council is pushing a bold plan to transform the road west of Light Square into green space, despite nearby ...
Oncocyte Prices $29.1 Million Equity Offering
Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial LaunchStrategic Partner Bio-Rad Invests, Boosts Support for ...
The Register on MSN13h
Meta's plan to erase 5% of workforce starts today
Intense year' ahead, warned Zuck. Got to spend billions on AI and work to stay out of Trump's bad books Meta has confirmed to ...
Adobe's AI assistant can now decipher contract jargon in your PDFs
Adobe has updated its Acrobat AI Assistant with a handy new feature that will help its users break down and understand ...
Taiwan News27m
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Business Wire6d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Arm gives up on killing off Qualcomm's vital chip license
Arm has given up on terminating one of its key licenses with Qualcomm, leaving the latter free to continue producing ...
EDITORIAL FROM ELSEWHERE: State budget should be kinder to businesses
We’re pleased Gov. Mark Dayton’s supplemental budget includes a $21.5 million one-time increase in Local Government Aid funding to cities as well as $21 million ongoing funds for ...
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...